DeepSnap-Deep Learning Approach Predicts Progesterone Receptor Antagonist Activity With High Performance

Yasunari Matsuzaka1, Yoshihiro Uesawa1

  • 1Department of Medical Molecular Informatics, Meiji Pharmaceutical University, Tokyo, Japan.

Insights

Deep learning models, using 3D chemical structures, accurately predict progesterone receptor (PR) antagonists. This novel DeepSnap-DL method outperforms traditional machine learning for drug discovery.

Area of Science:

  • Pharmacology and Cheminformatics
  • Artificial Intelligence in Drug Discovery

Background:

  • The progesterone receptor (PR) is a key therapeutic target for various diseases.
  • Modulating PR activity with agonists and antagonists is a promising treatment strategy, but clinical evidence is limited.
  • Deep learning (DL) offers advanced methods for classifying chemical compounds.

Purpose of the Study:

  • To develop and validate a novel DL-based quantitative structure-activity relationship (QSAR) strategy for predicting PR antagonists.
  • To assess the performance of the proposed DeepSnap-DL method against conventional machine learning approaches.

Main Methods:

  • A novel DL-based QSAR strategy, DeepSnap-DL, was developed using transfer learning.
  • The method utilizes 3D chemical structure images from multiple angles as input for DL classification.
  • Prediction models for PR antagonists were constructed and optimized.

Main Results:

  • The DeepSnap-DL method demonstrated high predictive performance for PR antagonists.
  • Optimization of parameters and image adjustments further improved model accuracy.
  • DeepSnap-DL significantly outperformed traditional machine learning methods in prediction accuracy.

Conclusions:

  • The DeepSnap-DL method is a powerful tool for QSAR, predicting various molecular activities and properties.
  • This approach can aid in identifying biological phenomena and accelerating drug discovery for PR-related conditions.

Related Concept Videos

Drug-Receptor Interaction: Antagonist01:28

Drug-Receptor Interaction: Antagonist

An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
4.5K
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
2.3K
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
3.6K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.1K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.7K